Medication info
Tenelitin M Extended-release Tablet 20/1000 mg

Tenelitin M Extended-release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletTeneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
Pink oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202736 · Approved 2022.07.01 · Insurance code 654702310

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication assists in blood sugar control for patients with type 2 diabetes by using teneligliptin and metformin together. When taken alongside dietary management and exercise, it can effectively manage blood sugar levels. This medication helps stabilize blood sugar, contributing to the prevention of complications. Therefore, it is suitable for patients with type 2 diabetes as an adjunct to a healthy lifestyle.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication can very rarely cause severe lactic acidosis, so caution is needed for this symptom. Lactic acidosis is a life-threatening condition, and if any unusual symptoms arise, immediate medical attention should be sought. This medication should not be administered to patients with moderate to severe renal impairment, and the renal function should be regularly monitored to ensure it is normal. Patients with impaired renal function may have increased risks of side effects due to drug accumulation in the body. Patients with cardiovascular diseases such as heart failure or acute myocardial infarction, and severely infected or trauma-affected patients should avoid or use this medication with caution. Before undergoing examinations with radiological iodine contrast agents, this medication should be discontinued at least 48 hours prior and resumed only after confirming normal kidney function post-exam. It is safer to avoid this medication in pregnant women, women who could become pregnant, and patients with liver dysfunction. Additionally, caution is needed for undernourished, starving, or weak patients. When used with insulin or sulfonylurea medications, the risk of hypoglycemia may increase, so care should be taken to be aware of hypoglycemic symptoms and to take quick action such as consuming glucose if symptoms appear. In case of abdominal pain, vomiting, or severe constipation indicating intestinal obstruction, discontinue the medication immediately and seek medical advice. This medication should not be given to patients who may experience hypoxic states due to liver dysfunction, pulmonary dysfunction, excessive alcohol consumption, dehydration, diarrhea, or vomiting. Elderly patients may have a risk of renal impairment, so dosage adjustments and regular renal function tests should be performed. During administration of this medication, vitamin B12 levels may decrease, so it is advisable to check vitamin B12 levels through regular blood tests. Skin conditions such as bullous pemphigoid may occur, so if any blisters or skin irritations develop, the doctor should be informed immediately. The safety and efficacy of this medication in children have not been established, so it is not used in pediatric patients. Alcohol consumption should be avoided during treatment, and the medication should be discontinued in cases of acute or chronic alcohol poisoning. The effectiveness of blood sugar control may vary depending on other medications used in conjunction with this one, so proper management in consultation with a doctor is necessary when taking other diabetes medications or drugs together.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigoid
  • acute pancreatitis
  • dizziness
Show 163 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • amylase elevation
  • lipase elevation
  • AST (GOT) elevation
  • ALT (GPT) elevation
  • GGT elevation
  • ALP elevation
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • CK (CPK) elevation
  • elevated serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweats
  • diabetic retinopathy
  • vision impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyp
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory disturbance
  • headache
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramp
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • gastroenteritis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • athlete's foot
  • subcutaneous abscess
  • Helicobacter pylori gastritis
  • vomiting
  • chronic gastritis
  • glossodynia
  • esophagitis
  • gastrointestinal motility disorder
  • gastrointestinal motility decrease
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • bruise
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • hearing loss
  • endolymphatic hydrops
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain the storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.